342644-97-7 Usage
Uses
Used in Pharmaceutical Industry:
(S)-2-[(1R,3aR,7aR)-octahydro-7a-methyl-4-oxo-4H-inden-1-yl]propyl 4-(9-hydroxynonan-1-oxy)benzenesulfonate is used as a potential pharmaceutical compound for [application reason]. Its unique structure and functional groups may offer novel therapeutic properties, which could be harnessed for the development of new drugs or drug delivery systems.
Used in Synthetic Organic Chemistry:
In the field of synthetic organic chemistry, (S)-2-[(1R,3aR,7aR)-octahydro-7a-methyl-4-oxo-4H-inden-1-yl]propyl 4-(9-hydroxynonan-1-oxy)benzenesulfonate is used as a key intermediate or building block for the synthesis of more complex molecules. Its chiral nature and diverse functional groups make it a valuable component in the creation of novel chemical entities with potential applications in various industries.
Used in Materials Science:
(S)-2-[(1R,3aR,7aR)-octahydro-7a-methyl-4-oxo-4H-inden-1-yl]propyl 4-(9-hydroxynonan-1-oxy)benzenesulfonate may also find applications in materials science, where its unique structure and functional groups could be utilized to develop new materials with specific properties. These materials could have potential uses in various applications, such as sensors, catalysts, or advanced materials for energy storage and conversion.
Check Digit Verification of cas no
The CAS Registry Mumber 342644-97-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,2,6,4 and 4 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 342644-97:
(8*3)+(7*4)+(6*2)+(5*6)+(4*4)+(3*4)+(2*9)+(1*7)=147
147 % 10 = 7
So 342644-97-7 is a valid CAS Registry Number.
342644-97-7Relevant academic research and scientific papers
Parallel synthesis of a vitamin D3 library in the solid-phase
Hijikuro,Doi,Takahashi
, p. 3716 - 3722 (2007/10/03)
A highly efficient synthesis of the vitamin D3 system on solid support is described. Two synthetic strategies for the solid-phase synthesis of vitamin D3 were developed. One is for 11-hydroxy analogues, and the other is for most other synthetic analogues. In the latter strategy, the sulfonate-linked CD-ring 58 was initially immobilized on PS-DES resin to give solid-supported CD-ring 63 (Scheme 10). Similarly, solid-supported CD-ring 63 was prepared by attachment of the CD-ring 10 to the chlorosulfonate resin 64. The vitamin D3 system was synthesized by Horner-Wadsworth-Emmons reaction of the A-ring phosphine oxide to a solid-supported CD-ring, followed by simultaneous introduction of the side chain and cleavage from resin with a Cu1-catalyzed Grignard reagent. Parallel synthesis of the vitamin D3 analogues was accomplished by a split and pool methodology utilizing radio frequency encoded combinatorial chemistry, and a manual parallel synthesizer for side chain diversification and deprotection. Additionally, we demonstrated the synthesis of various A-rings in a similar protocol for efficient preparation of building blocks.
